2016
DOI: 10.1158/1538-7445.sabcs15-p1-01-02
|View full text |Cite
|
Sign up to set email alerts
|

Abstract P1-01-02: Ki-67 proliferation index supported by digital quantitation in breast cancer: A comparative study

Abstract: Introduction: In cases of breast cancer, in addition to hormone receptor and Her2 status, proliferation markers (mitotic index, Ki-67 proliferation index = KIPI) also have therapeutic implications. The 2013 St. Gallen consensus guideline includes 14% cut-off point (20% by many experts) for KIPI to distinguish luminal A-like and luminal B-like subtypes, that might be associated with remarkable intra-/interobsever variability applied in daily pathological routine utilizing semiquantitative (SQ) "eye-balling" met… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles